Standard News

Hide Advertisement
  • Business
  • Culture
  • News
  • Technology
  • Trending
Site logo
ADVERTISEMENT
ADVERTISEMENT

New York to probe Mylan EpiPen contracts for schools

September 6, 2016 | By Reuters
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington

WASHINGTON (Reuters) – New York has opened a probe into whether Mylan Pharmaceuticals <MYL.O> broke antitrust law in writing contracts to provide EpiPens to some schools systems, state Attorney General Eric Schneiderman said in a statement on Tuesday.

A person briefed on the matter said the New York attorney general’s office has subpoenaed documents from Mylan over the EpiPen program.

Advertisement

There had been allegations that schools which had used Mylan’s EpiPen4Schools program, which gives many schools the devices for free, were contractually barred from buying products from Mylan competitors for a year. Senators Richard Blumenthal and Amy Klobuchar asked the Federal Trade Commission on Tuesday to investigate the allegation.

Mylan did not immediately respond to a request for comment.

(Reporting by Diane Bartz and David Shepardson; Editing by David Gregorio)

tagreuters.com2016binary_LYNXNPEC8514N-VIEWIMAGE

← Previous Post Next Post →
Advertisement - Continue reading below
Share  On Facebook

Here’s Why Educating Young Men Is the Key to Gender Equality

Director David Yates talks ‘Fantastic Beasts’

Pennsylvania governor nominates replacement for convicted attorney general

Obama, Senate Democrats urge Zika funding vote as reserves run low

Cast of ‘Suicide Squad’ defend film after rotten reviews

Hall of Fame Iron Man Favre almost flunked out by physical

Protesters slam North Dakota pipeline but company ‘committed’

Sentence upheld for former Subway pitchman Fogle in child porn case

Cannes on high alert ahead of film festival opening

Hungarian PM Orban endorses Donald Trump’s security proposals

load more Loading posts...

sidebar

ADVERTISEMENT
ADVERTISEMENT

sidebar-alt

  • About Us
  • Imprint
  • Contact Us
  • Terms of Service
  • Privacy Policy